A 3-year-old boy from rural Maharashtra presents with recurrent episodes of vomiting, lethargy, and developmental delay. His mother reports that symptoms worsen after high-protein meals. On examination, he is irritable with hepatomegaly. Laboratory investigations show: ammonia 180 µmol/L (normal <50), normal liver function tests, and normal blood glucose. Plasma amino acid analysis reveals elevated glutamine and alanine. Urine orotic acid is markedly elevated. Which enzyme deficiency is most likely responsible for this clinical presentation?

Explanation

## Clinical Diagnosis: Ornithine Transcarbamylase (OTC) Deficiency ### Key Biochemical Finding **Key Point:** OTC deficiency is the most common urea cycle disorder, accounting for ~50% of all cases. The markedly elevated urinary orotic acid is pathognomonic for this condition. ### Pathophysiology OTC catalyzes the condensation of carbamoyl phosphate (CP) and ornithine to form citrulline. When OTC is deficient: 1. Carbamoyl phosphate accumulates 2. CP is shunted into the pyrimidine synthesis pathway 3. Orotic acid (a pyrimidine precursor) accumulates and spills into urine 4. Ammonia cannot be efficiently converted to urea → hyperammonemia 5. Glutamine and alanine rise as alternative nitrogen disposal mechanisms ### Diagnostic Triad for OTC Deficiency | Finding | Mechanism | |---------|----------| | **Hyperammonemia** | Blocked urea cycle | | **Elevated urinary orotic acid** | CP shunting to pyrimidine synthesis | | **Elevated plasma glutamine & alanine** | Nitrogen scavenging pathways | ### Clinical Features Matching This Case - **Age of onset:** 3 years (can present from neonatal period to adulthood depending on severity) - **Triggers:** High protein intake, infections, stress - **Neurological signs:** Lethargy, irritability, developmental delay (ammonia neurotoxicity) - **Hepatomegaly:** Common in urea cycle disorders - **Normal LFTs:** Rules out primary hepatic disease **High-Yield:** OTC is X-linked dominant in inheritance; males are more severely affected than heterozygous females. ### Urea Cycle Overview ```mermaid flowchart TD A[Ammonia + Glutamine] --> B[Carbamoyl Phosphate<br/>CPS I] B --> C[Carbamoyl Phosphate +<br/>Ornithine] C -->|OTC| D[Citrulline]:::action D --> E[Argininosuccinate<br/>Synthetase] E --> F[Argininosuccinate] F -->|Argininosuccinate<br/>Lyase| G[Arginine] G -->|Arginase| H[Urea + Ornithine]:::outcome H --> I[Urea Excretion]:::outcome C -->|OTC BLOCKED| J[CP Accumulation]:::urgent J --> K[Shunt to Pyrimidine<br/>Synthesis] K --> L[↑ Orotic Acid<br/>in Urine]:::urgent ``` **Clinical Pearl:** In OTC deficiency, administering arginine (which bypasses the OTC step by providing citrulline precursor and activating arginase) is a key therapeutic strategy.